BCAB vs MA · $5.9M cap vs P/E 38, rev $32.79B
Bioatla Inc (BCAB) versus Mastercard Inc (MA) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
Latest reported MA revenue for 2025-12-31 was $32.79B. Net income was $14.97B. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. MA currently screens at market cap $515.12B and trailing P/E 38.4.
BCAB currently screens at market cap $5.9M. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Not investment advice. Open the BCAB and MA stock pages for the full models.
Not investment advice.